Structure Database (LMSD)

LM_ID Common Name Systematic Name Main Class Sub Class Mass Formula
LMSP0502AJ01 type IV A antigen(d18:1/16:0) GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1737.94 C80H143N3O37
LMSP0502BN01 - GalNAcbeta1-3(Fucalpha2-3Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1737.94 C80H143N3O37
LMSP0502BI01 - Fucalpha2-3(Galbeta1-4)GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1737.94 C80H143N3O37
LMSP0502BJ01 - Galbeta1-3(Fucalpha2-3GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1737.94 C80H143N3O37
LMSP0503AH01 - Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcb1-4Galb1-4Glc- (Ganglio series) [SP0503] 1737.94 C80H143N3O37
LMSP0503AL01 - GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcb1-4Galb1-4Glc- (Ganglio series) [SP0503] 1737.94 C80H143N3O37
LMSP0504BD01 - Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series) [SP0504] 1737.94 C80H143N3O37
LMSP0504AN01 - Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series) [SP0504] 1737.94 C80H143N3O37
LMSP0504AM01 - Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series) [SP0504] 1737.94 C80H143N3O37
LMSP0504AV01 - Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series) [SP0504] 1737.94 C80H143N3O37
LMSP0505AS01 Lex-7(d18:1/16:0) Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1737.94 C80H143N3O37
LMSP0505AM01 type II H antigen(d18:1/16:0) Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1737.94 C80H143N3O37
LMSP0505CI01 - Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1737.94 C80H143N3O37
LMSP0505CK01 - Galbeta1-3GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1737.94 C80H143N3O37
LMSP0505AH01 - Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1737.94 C80H143N3O37
LMSP0505AV01 - Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1737.94 C80H143N3O37
Total of 16 Records

Download LMSD record summary for Hex(4)-HexNAc(2)-Fuc-Cer 34:1;O2